HC Wainwright & Co. reiterates Buy rating on Legend Biotech, $65 price target

HC Wainwright & Co. reiterated their Buy rating on Legend Biotech's stock with a price target of $65.00.The price target implies an upside of 245.4% from the Sep 29 close of $18.82.Key takeaways from the analyst noteStrong Long-Term Efficacy of CARVYKTI: The five-year overall survival rate and medi…